| Literature DB >> 31888657 |
Keishi Sugimachi1, Tomohiro Iguchi2, Yohei Mano2, Masaru Morita3, Masaki Mori4, Yasushi Toh3.
Abstract
BACKGROUND: The management of infectious complications is important in pancreatoduodenectomy (PD). We sought to determine the significance of preoperative surveillance bile culture in perioperative management of PD.Entities:
Keywords: Bile culture; Multi-drug resistance; Pancreatoduodenectomy; Surgical site infection
Mesh:
Year: 2019 PMID: 31888657 PMCID: PMC6937703 DOI: 10.1186/s12957-019-1773-7
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Demographics and clinical characteristics of the study population
| Factor | Number | |
|---|---|---|
| Sex | Male/female | 45/24 |
| Age | years | 67.3 ± 9.9 |
| Disease | Pancreas tumor/bile duct tumor/duodenal tumor | 40/22/7 |
| Smoking history | Current (never or ever) | 17 (24.6%) |
| Body mass index | 22.3 ± 2.9 | |
| Diabetes mellitus | 22 (31.9%) | |
| Preoperative biliary stent placement | 34 (49.3%) | |
| Surgical procedure | PD/PPPD/SSPPD | 11/8/50 |
| Episode of preoperative cholangitis | 13 (18.9%) | |
Abbreviations: PD pancreatoduodenectomy, PPPD pylorus preserving pancreatoduodenectomy, SSPPD subtotal stomach preserving pancreatoduodenectomy
Postoperative complications and surveillance bile culture
| Complication | All cases | Bile culture positive | MDR pathogens positive | ||
|---|---|---|---|---|---|
| ( | ( | ( | |||
| Incisional SSI (%) | 6 (12) | 4 (14) | 0.53 | 4 (36) | 0.01 |
| Organ/space SSI (%) | 33 (65) | 18 (64) | 0.95 | 7 (63) | 0.93 |
| Bile leakage (%) | 4 (8) | 2 (7) | 0.84 | 1 (9) | 0.86 |
| Pancreatic fistula (%) | 21 (41) | 12 (43) | 0.79 | 4 (36) | 0.71 |
| Cholangitis (%) | 3 (6) | 2 (7) | 0.67 | 1 (9) | 0.63 |
| Enteritis (%) | 3 (6) | 2 (7) | 0.67 | 1 (9) | 0.63 |
| Clavien-Dindo ≥ 3 complication (%) | 16 (31) | 7 (25) | 0.28 | 3 (27) | 0.74 |
Abbreviations: SSI surgical site infection, MDR multi-drug resistance
Coincidence of pathogens in preoperative and postoperative culture
| Culture | Coincidence of pathogens | Non-coincidence of pathogens | |
|---|---|---|---|
| ( | ( | ||
| Drug sensitive pathogen positive ( | 3 (19%) | 13 (81%) | < 0.01 |
| Multi-drug resistant pathogen positive ( | 8 (80%) | 2 (20%) |
Risk factors associated with morbidity of organ/space surgical site infection
| Factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| oSSI(−) | oSSI(+) | hazard ratio (95% CI) | ||||
| Diagnosis | PDAC/others | 20/6 | 20/23 | 0.01 | ||
| Smoking history | (+)/(−) | 4/22 | 13/30 | 0.16 | 32.7 (1.65–647) | 0.02 |
| Operative time (min) | ≥ 360/≤ 359 | 13/13 | 32/11 | 0.04 | ||
| Blood loss (g) | ≥ 400/≤ 399 | 16/10 | 14/29 | 0.02 | ||
| Pancreatic texture | Soft/hard | 5/21 | 31/11 | < 0.01 | 17.2 (1.77–168) | 0.01 |
| Main pancreatic duct diameter (mm) | ≤ 3/≥ 4 | 9/17 | 26/13 | 0.01 | ||
| Preoperative bile culture | Positive/negative | 10/16 | 18/25 | 0.78 | ||
| Drug resistant pathogen in preoperative bile culture | Positive/negative | 4/22 | 7/36 | 0.92 | ||
Abbreviations: PDAC pancreatic adenocarcinoma, oSSI organ/space surgical site infection, CI confident interval